Banu ALPASLAN MESCİ (2017) “Can Pentraxin-3 be a Candidate Marker in the Follow-Up of the Patients With Behçet’s Disease?”, Archives of Rheumatology, 32(2), pp. 091–095. doi: 10.5606/ArchRheumatol.2017.6129.